A Phase II Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics/Pharmacodynamics of JSKN033 in Patients With Advanced Non-Small Cell Lung Cancer
Clinical trial NCT07283198 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07283198
- Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-10
- Primary completion
- 2027-08-30
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.